Location: Ukraine and Finland
The remote ECG monitoring device can predict heart attacks and strokes up to two months in advance.
Catching early signs of deteriorating health is often a factor in how likely a patient will have a positive outcome. Heart health is no exception, but heart conditions often go undetected until a significant event occurs.
Cardiolyse uses continuous monitoring combined with artificial intelligence to predict heart attacks and strokes up to two months before they occur. Once the doctor prescribes Cardiolyse, the patient is set up with a device that monitors vitals and can take an electrical heart trace or ECG recording. The ECG is completed within 30 seconds and is transmitted via Bluetooth.
The patient can access their data through the app, which displays their information in an easy-to-read way, including their biological heart age, heart risk and stress level, stamina scores and overall wellbeing. The doctor receives a comprehensive report of the patient’s information and is alerted immediately if an urgent event is detected.
The reports generated from the patient’s data can be used when deciding lifestyle changes and medication adjustments to keep the patient as healthy as possible. The user can repeat the monitoring to assess trends or changes.